- Home
- ADAP vs MAV Comparison
ADAP vs MAV Comparison
Compare ADAP & MAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- MAV
- Stock Information
- Founded
- ADAP 2008
- MAV 2003
- Country
- ADAP United Kingdom
- MAV United States
- Employees
- ADAP N/A
- MAV N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- MAV Finance Companies
- Sector
- ADAP Health Care
- MAV Finance
- Exchange
- ADAP Nasdaq
- MAV Nasdaq
- Market Cap
- ADAP 299.0M
- MAV 206.9M
- IPO Year
- ADAP 2015
- MAV N/A
- Fundamental
- Price
- ADAP $1.09
- MAV $8.85
- Analyst Decision
- ADAP Strong Buy
- MAV
- Analyst Count
- ADAP 3
- MAV 0
- Target Price
- ADAP $3.38
- MAV N/A
- AVG Volume (30 Days)
- ADAP 1.5M
- MAV 66.2K
- Earning Date
- ADAP 08-12-2024
- MAV 01-01-0001
- Dividend Yield
- ADAP N/A
- MAV 4.30%
- EPS Growth
- ADAP N/A
- MAV N/A
- EPS
- ADAP N/A
- MAV N/A
- Revenue
- ADAP $141,459,000.00
- MAV N/A
- Revenue This Year
- ADAP $172.21
- MAV N/A
- Revenue Next Year
- ADAP N/A
- MAV N/A
- P/E Ratio
- ADAP N/A
- MAV N/A
- Revenue Growth
- ADAP 99.90
- MAV N/A
- 52 Week Low
- ADAP $0.42
- MAV $6.37
- 52 Week High
- ADAP $2.05
- MAV $8.34
- Technical
- Relative Strength Index (RSI)
- ADAP 44.14
- MAV 73.81
- Support Level
- ADAP $1.17
- MAV $8.60
- Resistance Level
- ADAP $1.32
- MAV $8.82
- Average True Range (ATR)
- ADAP 0.09
- MAV 0.07
- MACD
- ADAP -0.01
- MAV 0.01
- Stochastic Oscillator
- ADAP 22.58
- MAV 92.19
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.
About MAV Pioneer Municipal High Income Advantage Fund Inc.
Pioneer Muni High Income Advantage Tr is a closed-end fund designed to pursue high current income exempt from regular federal income tax and as a secondary objective to seek capital appreciation. It predominantly invests in debt securities and other obligations issued by or on behalf of states, territories, and possessions of the United States and the District of Columbia and their political subdivisions, agencies, and instrumentalities, the interest on which is exempt from regular federal income tax.